Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach
VA Office of Research and Development · with VISN 2 Mental Illness Research, Education, and Clinical Center, VISN 17 Center of Excellence for Research on Returning War Veterans · NCT07356492
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 2700
- US sites recruiting
- 1
- Study start
- January 1, 2026
- Record last updated
- January 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration challenges during this transition are closely linked to increased suicide risk.
The Veteran Sponsorship Initiative (VSI) was developed to address this critical period by connecting Transitioning Servicemembers and Veterans (TSMVs) with trained, VA-certified peer sponsors. These sponsors help TSMVs navigate civilian life and access VA care. Early evaluations show that TSMVs matched with sponsors are more likely to report lower levels of reintegration difficulties, higher levels of social support, engage in VA services and report lower rates of depression and suicide risk.
This project enhances VSI by integrating predictive analytics-developed in partnership with Harvard Medical School and the DoW STARRS-LS team-to identify high-risk TSMVs before they leave the military. Those identified receive not only a sponsor but also targeted VA mental and health care services. This hybrid effectiveness-implementation study will evaluate the impact of this enhanced model (VSI+) on mental health outcomes and VA engagement among 2,700 high-risk TSMVs.
Method/Design
The purpose of this PEI proposal is to evaluate VSI expansion into VSI+ with enrollment occurring on four US Army installations (FY2026-2027). The study employs a pragmatic cluster-randomized trial with embedded mixed-method implementation evaluation to compare three arms:
- Transition as Usual (TAU)
- VSI Base= peer sponsorship and community support
- VSI+= VSI Base plus VA stepped care services
The evaluation is guided by the RE-AIM framework to assess:
- Reach (enrollment rates)
- Effectiveness (reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes)
- Adoption (site and staff uptake)
- Implementation (fidelity and feasibility)
- Maintenance (sustainability)
Study Aims
- Effectiveness: Evaluate the impact of VSI Base and VSI+ on reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes.
- Implementation: Assess the feasibility and fidelity of implementing VSI Base and VSI+ across multiple sites using a bundled strategy.
- Economic Impact: Estimate the budget impact of VSI Base and VSI+ on healthcare costs, including inpatient, emergency, and outpatient care.
Being studied: Onward Ops- receive peer sponsor and community support; VA stepped care services
Conditions: Reintegration Difficulties; Suicidal Ideation and Behaviors; Health; Connectedness
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- TSMVs must be 18-years of age or older
- Enroll prior to military discharge
- Be planning to transition from one of the target military installations' included in the evaluation during an active enrollment window
Exclusion Criteria
- The participants Army STARRS score cannot identify the TSMV as low risk nor as acute high risk for suicide
Recruiting US locations
James J. Peters VA Medical Center, Bronx, NY
The Bronx, NY 10468-3904
Site contact: Marianne S Goodman, MD · 718-584-9000 · marianne.goodman@va.gov
Study contacts (from the official record)
- Joseph C Geraci, PhD · (718) 584-9000 · Joseph.Geraci@va.gov
- David E Goodrich, EdD MS MA · David.Goodrich2@va.gov
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1